YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Onyx Pharma Could Draw $180 Per Share


July 1, 2013 | Over the weekend, Onyx Pharmaceuticals stirred up speculation over a buyout. Amgen reportedly offered $120/share, and Onyx responded by issuing a call for other suitors. This morning, pundits speculate that the price could hit $180/share. Forbes
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1


For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 , tmanning@healthtech.com.